ArticlePNAS nexus2023

A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery.

Sopisa Benjakul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.